## ALB: Albemarle Corporation - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_10 -0.1% below STRENGTH zone (3.0-6.0%); PEG 4.55 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($114.29)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Baird Raises Albemarle (ALB) Price Target as Lithium Market Optimism Grows**
- Source: Insider Monkey | 20251203T145600 | Bullish | Relevance: 99%
- Baird upgraded Albemarle (ALB) to Neutral from Underperform and raised its price target to $113 from $81, citing optimism around lithium demand for energy storage. Albemarle reported strong Q3 2025 results with revenues of $1.3 billion and adjusted EBITDA up 7% to $226 million, expecting positive free cash flow of $300â€“$400 million for the full year 2025. The company is also divesting stakes in Ketjen and Eurecat for approximately $660 million, strengthening its financial position.

**2. Rhumbline Advisers Lowers Stake in Albemarle Corporation $ALB**
- Source: MarketBeat | 20251201T105205 | Neutral | Relevance: 99%
- Rhumbline Advisers reduced its stake in Albemarle Corporation by 2.0% in the second quarter, selling 4,730 shares but still holding 236,207 shares valued at $14.8 million. Despite this, institutional ownership of Albemarle remains high at 92.87%, with several other funds increasing their positions. Analysts maintain a "Hold" rating with a consensus target price of $101.29, although recent price target adjustments from firms like Jefferies and Deutsche Bank show varied outlooks.

**3. Baird Raises Albemarle (ALB) Price Target as Lithium Market Optimism Grows**
- Source: Finviz | 20251203T145600 | Bullish | Relevance: 98%
- Baird upgraded Albemarle Corporation (ALB) to Neutral from Underperform and increased its price target to $113 from $81, citing optimism around lithium demand for energy storage, particularly in stationary storage. The company reported strong Q3 2025 results with revenues of $1.3 billion and adjusted EBITDA up 7%, and expects to generate positive free cash flow of $300-$400 million for the full year. Albemarle is also divesting stakes in Ketjen and a joint venture for approximately $660 million in pre-tax proceeds.

**4. Quantbot Technologies LP Acquires 64,763 Shares of Albemarle Corporation $ALB**
- Source: MarketBeat | 20251203T133248 | Somewhat-Bullish | Relevance: 97%
- Quantbot Technologies LP increased its stake in Albemarle Corporation by 36.2% in Q2, acquiring 64,763 shares, bringing its total to 243,551 shares valued at $15.263 million. Other institutional investors like ProShare Advisors LLC, FengHe Fund Management Pte. Ltd., PGGM Investments, Norges Bank, and Nuveen LLC also increased or initiated positions, resulting in institutional ownership of 92.87%. Albemarle recently reported an EPS beat, announced a quarterly dividend of $0.405 per share, and received updated price targets and ratings from several analysts.

**5. Here Are Tuesday's Top Wall Street Analyst Research Calls: Albemarle, Circle Internet, Cloudflare, Danaher, Inspire Medical, Six Flags, Workday and More**
- Source: 24/7 Wall St. | 20251202T131551 | Somewhat-Bullish | Relevance: 81%
- This article provides an overview of market performance on Monday, December 1st, 2025, noting a "risk off" session with all major indices closing lower, and highlights key movements in futures, bonds, oil and gas, gold, and cryptocurrencies. It then details top Wall Street analyst upgrades, downgrades, and initiations for several companies, including Albemarle, Six Flags, Inspire Medical Systems, Circle Internet Group, Cloudflare, Danaher, and Workday, among others, for Tuesday, December 2nd, 2025.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 10, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | UBS | $185 | $107 | +73% |
| 2025-12-03 | Deutsche Bank | $125 | $110 | +14% |
| 2025-12-02 | Baird | $113 | $81 | +40% |
| 2025-11-19 | BMO Capital | $136 | $125 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | UBS | up | Buy |
| 2025-12-03 | Deutsche Bank | main | Hold |
| 2025-12-02 | Baird | up | Neutral |
| 2025-11-19 | BMO Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($0.03M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (-0.8%)
- Capital World Invest: 7.0% (+0.2%)
- Blackrock Inc.: 7.0% (-0.1%)
- State Street Corpora: 4.8% (-15.4%)
- Franklin Resources, : 2.8% (-42.8%)

### Key Risks

1. Valuation stretched: PEG 4.5x requires aggressive growth execution.
2. Elevated short interest (13.9%): bears positioning against stock.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 10 raises (avg +23%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 4.55 signals overvaluation risk, limited margin of safety. Balance sheet: strong liquidity (2.3x). Analyst sentiment positive (10 raises, avg +23%). Institutional flow bearish (6 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $15.2B |
| Beta | 1.43 |
| 52W Range | $49.43 - $132.90 |
| Short Interest | 13.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.55 |
| Forward P/E | 176.1 |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_10 deteriorating from 3.8% to -0.1% (-3.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.1pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.57), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.14% (CS: 52) | Neutral |
| RSI_14 | 66.0 | Neutral |
| MACD Histogram | 0.57 | Bullish |
| vs SMA20 | 1.097x | Above |
| vs SMA50 | 1.244x | Above |
| vs SMA200 | 1.634x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $126.49
- **Stop Loss:** $114.29 (9.6% risk)
- **Target:** $138.69 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 77
- **Position Value:** $9,739.73
- **Portfolio %:** 9.74%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX at 16 is below median, showing calm, but breadth is only moderate and put/call is neutral, suggesting neither strong bullish nor defensive extremes. Key drivers are rising Fed rate-cut odds from soft ADP jobs data, mixed earnings across sectors, and ongoing AI/tech strength offset by caution in cyclicals and banks. Positioning should remain selective and neutral, awaiting more decisive macro or earnings signals.*

### Earnings

**Next:** 2026-02-11 (Est: $-0.67)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.88 | $-0.19 | +78.3% |
| 2025Q2 | $-0.81 | $0.11 | +113.5% |
| 2025Q1 | $-0.68 | $-0.18 | +73.5% |
| 2024Q4 | $-0.67 | $-1.09 | -63.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*